Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


3Q EARNINGS: Sanofi underwhelms but believes the worst is over

This article was originally published in Scrip

Executive Summary

Sanofi may not quite be cheering its underwhelming third-quarter results, but there is a definite sense that the company is relieved by the lack of drama after its Q2 results fireworks. Amid figures that show nominal sales growth and disappointing EPS, CEO Christopher Viehbacher emphasized that the worst was over for Sanofi, with the main impact of the patent cliff now behind the pharma giant.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts